MYCELX Technologies (UK) Today

MYX Stock   37.50  1.50  4.17%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 29

 
High
 
Low
Below Average
MYCELX Technologies is trading at 37.50 as of the 22nd of November 2024, a 4.17% increase since the beginning of the trading day. The stock's lowest day price was 36.9. MYCELX Technologies has about a 29 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for MYCELX Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.

Moving together with MYCELX Stock

  0.8SYME SupplyMe Capital PLCPairCorr
  0.74GVMH Grand Vision MediaPairCorr
  0.65DGI DG Innovate PLCPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

MYCELX Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. MYCELX Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding MYCELX Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO DirectorConnie Mixon
Business ConcentrationIndustrials, Machinery (View all Sectors)
MYCELX Technologies (MYX) is traded on London Exchange in UK and employs 5 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MYCELX Technologies's market, we take the total number of its shares issued and multiply it by MYCELX Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. MYCELX Technologies has 24.36 M outstanding shares. MYCELX Technologies generates negative cash flow from operations
Check MYCELX Technologies Probability Of Bankruptcy
Ownership Allocation
MYCELX Technologies secures a total of 24.36 Million outstanding shares. 30% of MYCELX Technologies outstanding shares are owned by institutions. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MYCELX Ownership Details

MYCELX Technologies Risk Profiles

Although MYCELX Technologies' alpha and beta are two of the key measurements used to evaluate MYCELX Technologies' performance over the market, the standard measures of volatility play an important role as well.

MYCELX Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in MYCELX Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Analyst Advice Now

   

Analyst Advice

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

MYCELX Technologies Corporate Executives

Elected by the shareholders, the MYCELX Technologies' board of directors comprises two types of representatives: MYCELX Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MYCELX. The board's role is to monitor MYCELX Technologies' management team and ensure that shareholders' interests are well served. MYCELX Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MYCELX Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
John SrCoFounder EmeritusProfile
Kimberly SlaytonCFO SecretaryProfile

Other Information on Investing in MYCELX Stock

MYCELX Technologies financial ratios help investors to determine whether MYCELX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MYCELX with respect to the benefits of owning MYCELX Technologies security.